FundedIQ
Biotechnology

Curadel Surgical Innovations: Funding, Investors & Team (Sep 2026)

Curadel Surgical Innovations oversees the complete process of Curadel's FLARE contrast agents for image-guided surgery.

www.curadelsurgicalinnovations.com Natick, United States 11-50 employees
Total raised
$14.5M
Rounds
1
Latest
Undisclosed round
Oct 2025

Curadel Surgical Innovations has raised $14.5M across 1 funding round on record, the most recent an undisclosed round of $14.5M announced in Oct 2025.

That round is in line with the $15M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Curadel Surgical Innovations Company Profile and Key Stats

Total funding raised
$14.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$14.5M in Oct 2025
Employees
11-50
reported band
Headquarters
Natick, United States

Latest funding round on record: Oct 2025.

Curadel Surgical Innovations Funding Rounds

Date
Round
Amount
Undisclosed round
$14.5M

Curadel Surgical Innovations Founders and Leadership Team

Name
Role
Contact
John Frangioni
Founder
John V Frangioni
CEO
Locked

Contact details for the Curadel Surgical Innovations team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Curadel Surgical Innovations Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
29,722
$7.5M

Curadel Surgical Innovations' latest round of $14.5M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Curadel Surgical Innovations in Biotechnology and Natick

Companies Similar to Curadel Surgical Innovations

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific…

Undisclosed round

Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading…

Undisclosed round $5.3M

Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures…

Seed $8.0M

Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.

Series A $65.0M

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and…

Series A $80.0M

Excellergy develops portfolio of trifunctional effector cell response inhibitors (ECRIs) to combat severe…

Series A $70.0M

Ventuno Biotech is a biotech company that is developing innovative cancer therapies.

Seed $2.3M

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.

Series A $32.0M

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the…

Series A $185M

Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies

Pre-Seed $3.5M

Treating the seeds of cancer

Seed $4.7M

Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology.

Seed $6.7M

Curadel Surgical Innovations Funding FAQs

What does Curadel Surgical Innovations do?

Curadel Surgical Innovations oversees the complete process of Curadel's FLARE contrast agents for image-guided surgery.

How much funding has Curadel Surgical Innovations raised?

Curadel Surgical Innovations has raised $14.5M across 1 round on record. The most recent is an undisclosed round of $14.5M announced in Oct 2025.

When did Curadel Surgical Innovations last raise funding?

Curadel Surgical Innovations' most recent funding round on record is an undisclosed round of $14.5M, announced in Oct 2025.

Who founded Curadel Surgical Innovations?

FundedIQ lists John Frangioni (Founder) at Curadel Surgical Innovations.

Who is the CEO of Curadel Surgical Innovations?

John V Frangioni is listed as CEO at Curadel Surgical Innovations.

Where is Curadel Surgical Innovations headquartered?

Curadel Surgical Innovations is based in Natick, United States.

How many employees does Curadel Surgical Innovations have?

Curadel Surgical Innovations is in the 11-50 employee band.

How does Curadel Surgical Innovations' funding compare to other Biotechnology startups?

Curadel Surgical Innovations' latest round of $14.5M is in line with the $15M median round size for Biotechnology companies on FundedIQ across 16 tracked companies over the last two years.

About FundedIQ's Curadel Surgical Innovations Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Curadel Surgical Innovations is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.